Rifampin reduces the analgesic effect of transdermal fentanyl.
Takane
Hiroshi
H
Nosaka
Aya
A
Wakushima
Hannosuke
H
Hosokawa
Kazuyo
K
Ieiri
Ichiro
I
D000230:Adenocarcinoma / Q000473:pathology; D000279:Administration, Cutaneous; D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular / Q000009:adverse effects*; D004347:Drug Interactions; D005283:Fentanyl / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000556:secondary; D008297:Male; D010146:Pain / Q000150:complications / Q000188:drug therapy*; D010307:Parotid Neoplasms / Q000473:pathology; D012293:Rifampin / Q000009:adverse effects*; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy
D000701:Analgesics, Opioid; D000904:Antibiotics, Antitubercular; D005283:Fentanyl; D012293:Rifampin